Hashimoto Y, Mizutani M
Department of Reproductive and Developmental Toxicology, Hatano Research Institute, Food and Drug Safety Center, Kanagawa, Japan.
J Vet Med Sci. 1991 Aug;53(4):643-9. doi: 10.1292/jvms.53.643.
Micrencephalic neonatal pups were obtained from pregnant Crj:CD (SD) rats once treated with 5 mg/kg of N-methyl-N-nitrosourea (MNU) or 40 mg/kg of methylazoxymethanol (MAM) on day 12, 13, 14 or 15 of gestation (vaginal plug = day 0). They were reared by their own mothers and were subjected to various neurobehavioral tests during the suckling period, days 0 to 22 after birth. The brain weights in the MNU- and MAM-treated pups on postnatal day 22 were significantly less than those in the control pups. These micrencephalic pups were retarded in neurobehavioral ontogeny. By several tests, each of them showed an impaired performance such as paired limb movement, clumsy locomotion or hyperreflexive reaction. These behavioral disorders appeared different according to the day of treatment, without any substantial difference between the test compounds, MNU and MAM. The findings suggest that the different neurobehavioral characteristics in the micrencephalic pups may reflect their different brain disorders induced by the test compounds given on the different period of the treatment.
在妊娠第12、13、14或15天(以阴道栓出现日为第0天),给怀孕的Crj:CD(SD)大鼠一次性注射5 mg/kg的N-甲基-N-亚硝基脲(MNU)或40 mg/kg的甲基氧化偶氮甲醇(MAM),从而获得小脑发育不全的新生幼鼠。这些幼鼠由其生母抚养,并在出生后第0至22天的哺乳期接受各种神经行为测试。出生后第22天,接受MNU和MAM处理的幼鼠的脑重量显著低于对照幼鼠。这些小脑发育不全的幼鼠在神经行为个体发育方面存在迟缓。通过多项测试,每只幼鼠都表现出如双肢运动、笨拙的运动或反射亢进反应等行为表现受损。这些行为障碍根据给药日的不同而有所不同,测试化合物MNU和MAM之间没有任何实质性差异。研究结果表明,小脑发育不全幼鼠不同的神经行为特征可能反映了在不同治疗时期给予测试化合物所诱发的不同脑部病变。